-
- 1800 2010
- EN
Gentis news
Array
(
[0] => stdClass Object
(
[id] => 1426
[id_crawler] =>
[category_product] => NULL
[thumbnail] => huyen.8.2021/wweb.png
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 0
[displayed_time] => 2026-04-20
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2026-04-21 08:55:25
[updated_time] => 2026-04-21 10:18:20
[files] =>
[salary] =>
[time] =>
[created_by] => 1
[is_table_content] => 0
[language_code] => en
[slug] => Announcement-Update-on-non-invasive-prenatal-paternity-DNA-testing-service
[title] => Announcement: Update on non-invasive prenatal paternity DNA testing service
[description] => In our continuous effort to enhance service quality and deliver the best customer experience, Eurofins GENTIS is pleased to announce updates to our non-invasive prenatal paternity DNA testing service, featuring significant improvements in turnaround time and efficiency.
[content] => 1. Key Enhancements
The prenatal paternity DNA testing service at Eurofins GENTIS has been upgraded with the following advantages:
- Earlier testing: Available from as early as the 7th week of pregnancy, enabling customers to make timely decisions.
- Faster results: Flexible turnaround options from 3–10 days to meet diverse needs.
- Absolute safety: A non-invasive method using only the mother’s blood sample, ensuring no risk to the fetus.
2. Advantages of the Testing Method
Non-invasive prenatal paternity DNA testing is a modern solution highly regarded for:
- Requiring only 7–10 ml of the mother’s venous blood
- Early testing capability (from the 7th week of pregnancy)
- High accuracy of up to 99.9%
- Strict confidentiality of customer information
3. Flexible Service Packages
Eurofins GENTIS offers various options to suit customer needs:
- Standard package: Results within 7–10 days
- 7-day express package: Optimized turnaround time at a reasonable cost
- Super express package (3–5 days): Ideal for urgent result requirements
4. Sample Requirements and Conditions
Test samples include:
- Mother: Venous blood
- Alleged father: Blood, buccal swab, nails, hair with roots, or other special samples
Requirements: Ultrasound results confirming gestational age
5. Eurofins GENTIS Quality Commitment
With internationally accredited laboratory systems such as CAP, ISO 9001, and ISO 15189, Eurofins GENTIS is committed to delivering DNA testing services that are:
- Reliable
- Accurate
- Fast
We not only provide test results but also support our customers with in-depth consultation services delivered with dedication and strict confidentiality.
[content_more] => [meta_title] => Announcement: Update on non-invasive prenatal paternity DNA testing service [meta_description] => In our continuous effort to enhance service quality and deliver the best customer experience, Eurofins GENTIS is pleased to announce updates to our non-invasive prenatal paternity DNA testing service, featuring significant improvements in turnaround time [meta_keyword] => ADN [thumbnail_alt] => [post_id] => 1426 [category_id] => 14 ) [1] => stdClass Object ( [id] => 1425 [id_crawler] => [category_product] => NULL [thumbnail] => fe1133a3ddce5c9005df.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-16 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-16 09:33:00 [updated_time] => 2026-04-17 15:22:09 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Genetic-testing-ecosystem-in-reproductive-support-at-Eurofins-GENTIS [title] => Genetic testing ecosystem in reproductive support at Eurofins GENTIS [description] => The journey of finding and welcoming a child is one of the most sacred milestones for every family. However, alongside happiness comes many concerns, especially those related to reproductive health and genetic factors that may affect fertility and fetal development. In this context, proactive testing, screening, and early detection of potential risks play an essential role. [content] =>Understanding this need, Eurofins GENTIS has developed a comprehensive, scientific, and specialized genetic testing ecosystem for reproductive support. This system is designed to accompany couples at every stage – from preconception, through assisted reproduction, to pregnancy monitoring – helping optimize the chances of having a healthy baby.
Testing for both partners – the foundation for a strong start
Before beginning the journey to parenthood, a comprehensive assessment of reproductive health and genetic risks for both partners is essential. This is a critical first step to detect early abnormalities that may affect fertility or be passed on to the next generation.
Testing for men focuses on evaluating sperm quality, genetic structure, and fertility-related factors. Key tests include:
- AZF: detects Y chromosome microdeletions – a common cause of male infertility
- Sperm DNA fragmentation: evaluates DNA damage in sperm
- Ultragen: screens for genetic disorders
- CFTR gene: identifies risks related to cystic fibrosis
- Karyotyping: detects chromosomal abnormalities in number and structure
- Thalassemia screening
- Carrier screening panel of 28 recessive genes
Testing for women not only evaluates fertility but also identifies factors that may affect pregnancy:
- AMH: assesses ovarian reserve
- HPV: screens for viruses causing
- Cervical cancer
- Karyotyping
- Thalassemia screening
- STDs: screening for sexually transmitted diseases
- FSHR gene: related to ovarian stimulation response
- NK test: evaluates immune cell activity
- Thrombophilia: assesses inherited clotting disorders
- Ultragen
- Carrier screening panel of 28 recessive genes
Completing these tests provides doctors with a comprehensive understanding, enabling them to design the most appropriate and personalized treatment and reproductive support plan for each couple.
Embryo testing and implantation conditions – optimizing success rates
In modern assisted reproductive techniques such as in vitro fertilization (IVF), selecting healthy embryos and ensuring optimal uterine conditions are key factors determining success.
Embryo testing at Eurofins GENTIS analyzes the genetic material of embryos before transfer, helping select those with the best developmental potential:
- PGT-A/SR: screens for chromosomal number and structural abnormalities
- PGT-M: detects single-gene disorders
- PGT-One, PGT-MAX 1, PGT-NEXT,
- PGT-Upgrade, PGT-FAST: optimized testing packages based on different needs
- ASEM test (non-invasive PGT): a non-invasive method that minimizes impact on embryos
At the same time, testing for implantation conditions plays an important role in evaluating uterine receptivity:
- Genratest: analyzes gene expression related to embryo implantation
- PMTest: evaluates the implantation window to determine the optimal embryo transfer timing
The combination of embryo testing and uterine condition assessment can significantly improve IVF success rates while reducing the risk of miscarriage or implantation failure.
Maternal and fetal health testing – comprehensive pregnancy protection
After successful conception, monitoring maternal health and fetal development is an essential next step. Tests during this stage help detect early complications and genetic abnormalities in the fetus.
Key tests include:
- Preeclampsia screening: identifies risks of serious pregnancy complications
- Antiphospholipid testing: detects conditions increasing the risk of miscarriage and thrombosis
- NIPT (GenBasic/GenEva): non-invasive prenatal testing to detect common chromosomal abnormalities such as Down syndrome, Edwards syndrome, and Patau syndrome
- Newborn screening
- Pediatric testing
These tests not only protect maternal health but also ensure close monitoring of fetal development, enabling timely intervention when necessary.
Comprehensive support – enhancing the health of future generations
With a diverse and specialized testing ecosystem built for each stage, Eurofins GENTIS provides a comprehensive solution for reproductive support. Beyond testing services, the company also accompanies families through consultation, guidance, and personalized reproductive health planning.
From preconception preparation and IVF support to pregnancy monitoring, each test serves as an important “piece of the puzzle,” contributing to a safer and more complete journey for both mother and baby.
Proactive testing is the best way to protect your child’s future from the very beginning. By understanding health status and genetic risks, couples can make informed decisions with confidence, aiming for a healthy pregnancy and a higher-quality future generation.
For detailed consultation on the appropriate testing pathway, please contact hotline: 1800 2010
[content_more] => [meta_title] => Genetic testing ecosystem in reproductive support at Eurofins GENTIS [meta_description] => The journey of finding and welcoming a child is one of the most sacred milestones for every family. However, alongside happiness comes many concerns, especially those related to reproductive health and genetic factors that may affect fertility and fetal d [meta_keyword] => Supported ,Reproductive support tests [thumbnail_alt] => [post_id] => 1425 [category_id] => 14 ) [2] => stdClass Object ( [id] => 1424 [id_crawler] => [category_product] => NULL [thumbnail] => bld/anh-bao.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-01 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-15 10:08:44 [updated_time] => 2026-04-16 13:43:08 [files] => [salary] => [time] => [created_by] => 1 [is_table_content] => 0 [language_code] => en [slug] => Eurofins-GENTIS-announces-appointment-of-chief-executive-officer [title] => Eurofins GENTIS announces appointment of chief executive officer [description] => Eurofins Genetic Testing Services Joint Stock Company (Eurofins GENTIS) has officially announced the appointment of Dr Nguyen Quang Vinh as chief executive officer, effective from March 23, 2026. [content] =>With more than 15 years of dedication to Eurofins GENTIS, Dr Nguyen Quang Vinh is not only one of the founding members but also a key figure in building the company’s scientific and operational foundation. Throughout its development journey, he has held many important roles, particularly in technical expertise and laboratory management – the core elements that define the credibility of a genetic testing organization.
Dr Nguyen Quang Vinh – newly appointed chief executive officer of Eurofins GENTIS
Established in 2010, Eurofins GENTIS has gradually affirmed its position with two large-scale laboratories in Hanoi and Ho Chi Minh City, achieving multiple international certifications such as CAP, ISO 9001:2015, ISO 15189:2022, and ISO/IEC 27001:2022. Each year, the system processes nearly 300,000 genetic test samples, meeting the growing demands of the market.
Beyond laboratory capabilities, the company has developed a network of more than 50 sample collection points nationwide, enabling customers to access services quickly and conveniently. At the same time, Eurofins GENTIS is a trusted partner of many major hospitals and healthcare organizations, as well as leading global biotechnology corporations such as Illumina, Qiagen, and Sigma.
The appointment of Dr Nguyen Quang Vinh to the highest executive position is expected to bring a new momentum to Eurofins GENTIS. With his strong background in genetics and extensive management experience, he is considered well-equipped to lead the company into its next phase of development.
Under the leadership of the new chief executive officer, Eurofins GENTIS is expected to further invest in next-generation sequencing (NGS) technologies, expand its testing portfolio, and enhance service quality to meet international standards. In addition, strengthening partnerships with hospitals, fertility centers, and healthcare organizations both domestically and internationally will be a key focus to expand its service ecosystem and reinforce its pioneering role in genetic testing and diagnostics in Vietnam and the region.
Beyond business growth, Eurofins GENTIS remains committed to its mission of “enhancing the physical and intellectual well-being of Vietnamese people” by bringing advanced genetic solutions closer to the community. This commitment continues to be the guiding principle that helps the company build trust and credibility with its customers over the years.
[content_more] => [meta_title] => Eurofins GENTIS announces appointment of chief executive officer [meta_description] => Eurofins Genetic Testing Services Joint Stock Company (Eurofins GENTIS) has officially announced the appointment of Dr Nguyen Quang Vinh as chief executive officer, effective from March 23, 2026. This marks an important milestone in the company’s long-ter [meta_keyword] => GENTIS,New CEO [thumbnail_alt] => [post_id] => 1424 [category_id] => 14 ) [3] => stdClass Object ( [id] => 1423 [id_crawler] => [category_product] => NULL [thumbnail] => e4e92a4ae82969773038.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-04-15 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-04-15 09:49:46 [updated_time] => 2026-04-16 13:40:51 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Working-announcement-during-Hung-Kings-Commemoration-Day-and-April-30-May-1-holiday [title] => Working announcement during Hung Kings’ Commemoration Day and April 30 – May 1 holiday [description] => Dear valued customers and partners, [content] =>Hung Kings’ Commemoration Day (10th day of the third lunar month) and the April 30 – May 1 holiday are important milestones with special significance for the Vietnamese people. During this solemn and meaningful time, many agencies, organizations, and businesses temporarily suspend operations for the holiday. However, with the aim of ensuring work continuity and delivering the best service experience to customers, Eurofins GENTIS would like to announce its working plan during the holiday as follows:
- maintaining operations throughout the holiday
To promptly meet the needs of our valued customers and partners, Eurofins GENTIS will continue normal operations on Hung Kings’ Commemoration Day (10th day of the third lunar month).
This means that all departments within our system will operate according to the standard working schedule without interruption, including:
- Laboratory department
- Customer service department
- Sample collection and result delivery department
Maintaining operations during the holiday is one of our efforts to ensure work progress is not affected, especially for time-sensitive services that require prompt processing.
Eurofins GENTIS understands that for our customers, every service request is important and requires the highest level of accuracy. Therefore, even during the holiday period, we remain committed to:
- Maintaining stable performance without delays or interruptions
- Ensuring quick response times and timely support for all inquiries and requests
- Upholding service quality and strictly complying with professional standards and quality control processes
We believe that consistency and professionalism at all times – including holidays – are key factors in building long-term trust and relationships with our customers and partners.
- enhancing customer support during the holiday
During the holiday period, demand for consultation and services may increase as customers have more time to arrange personal matters. Understanding this, Eurofins GENTIS has proactively prepared resources to:
- Ensure the consulting team is always ready to support
- Enhance the capacity to receive and process requests
- Reduce customer waiting time
We always place customer experience at the center, and all processes are optimized to provide maximum convenience and satisfaction.
If you need consultation, support, or have any inquiries related to our services, please contact us via: hotline: 1800 2010
Our team is always ready to listen and assist you with dedication, promptness, and efficiency.
On the occasion of Hung Kings’ Commemoration Day, Eurofins GENTIS would like to express our sincere thanks to our valued customers and partners for your trust, support, and companionship over the years.
Your support is a great motivation for us to continuously improve service quality, optimize processes, and pursue sustainable development.
We wish our valued customers and partners a peaceful, joyful, and meaningful holiday with your family and loved ones.
Sincerely,
Eurofins GENTIS
With the desire to accompany families during this special stage, Eurofins GENTIS collaborated with Hanoi Andrology and Infertility Hospital to successfully organize a prenatal class with the theme “PROPER VACCINATION – PROTECTING MOTHERS, STRENGTHENING BABIES”. The program took place in a warm and friendly atmosphere, attracting many expectant mothers and families preparing to welcome their babies.
From the very beginning, the class became an open sharing space where expectant mothers could freely ask questions, express concerns, and receive dedicated advice from experts. In particular, the session led by Dr Do Thi Huyen on the topic “Vaccination in pregnant women – a shield protecting the health of mother and baby” provided practical, scientific, and easy-to-understand information.
One of the most discussed topics was why vaccination is necessary during pregnancy. Through the doctor’s presentation, participants clearly understood that vaccination not only protects mothers from dangerous infectious diseases but also creates an immune “shield” for the fetus from the womb. This is an essential preparation step to reduce the risk of complications during pregnancy and protect the baby in the first months of life, when the immune system is still immature.
In addition, important vaccination milestones during pregnancy were analyzed in detail. Essential vaccines such as tetanus, influenza, and pertussis were clearly explained in terms of appropriate timing, effectiveness, and necessary precautions. This helps expectant mothers proactively build a safe and scientific vaccination plan for themselves.
Beyond providing knowledge, the class also addressed many practical concerns commonly raised by mothers, such as whether vaccination affects the fetus, what to do before and after vaccination, and how to monitor post-vaccination reactions to ensure safety. Clear and practical explanations from the doctor helped ease common worries and provided reassurance throughout pregnancy care.
A special highlight of the program was not only its professional content but also the emotional connection among participants. Expectant mothers had the opportunity to meet, interact, and share personal experiences. This sense of empathy and sharing created a warm and supportive environment where no one felt alone on the journey to motherhood.
For Eurofins GENTIS, participating in community health education programs, especially prenatal classes, is part of its commitment to delivering sustainable value to society. Beyond providing high-quality testing and diagnostic services, the organization aims to spread accurate medical knowledge and enhance public awareness of proactive healthcare.
The collaboration with Hanoi Andrology and Infertility Hospital in this program once again affirms a shared effort to build a comprehensive support system for families. From examination and treatment to education and counseling, all activities aim to help couples experience a safe, healthy, and fulfilling pregnancy journey.
As the class concluded, what remained was not only valuable knowledge but also a visible sense of relief and reassurance on the faces of expectant mothers. Bright smiles and hopeful eyes clearly reflected the value the program brought. Each mother left the session feeling more confident in caring for herself and protecting her baby.
It can be said that the prenatal class “PROPER VACCINATION – PROTECTING MOTHERS, STRENGTHENING BABIES” was not just a knowledge-sharing session but also a source of inspiration and emotional support for families. With the right information and guidance from experts, the pregnancy journey becomes much smoother and more meaningful.
In the future, Eurofins GENTIS aims to continue delivering more practical programs to support families in welcoming new life. Because every healthy newborn is not only a joy for each family but also for the entire community.
[content_more] => [meta_title] => The prenatal class “Proper vaccination – protecting mothers, strengthening babies” concluded with ma [meta_description] => On the journey to welcome a little angel, every mother carries a mix of happiness and concern. Pregnancy is not only a physical transformation but also a journey of learning, preparation, and adaptation to bring the best for the baby from the very beginni [meta_keyword] => GENTIS,prenatal cleass [thumbnail_alt] => [post_id] => 1422 [category_id] => 14 ) [5] => stdClass Object ( [id] => 1418 [id_crawler] => [category_product] => NULL [thumbnail] => dsc03012.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-03-29 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-03-30 09:04:09 [updated_time] => 2026-04-16 10:00:17 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-participates-in-the-workshop-Advances-in-Reproductive-Medicine-13-updating-solutions-to-improve-IVF-success-rates [title] => Eurofins GENTIS participates in the workshop “Advances in Reproductive Medicine 13”: updating solutions to improve IVF success rates [description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support successfully organized the scientific workshop “Advances in Reproductive Medicine 13” with the main theme: “How to improve the success rate of IVF cycles”. [content] =>A prestigious scientific forum in the field of reproductive support
Amid the increasing rate of infertility and the growing demand for access to modern assisted reproductive technologies, this year’s workshop holds special significance. It is not only a place to update the latest advances in reproductive medicine but also serves as a scientific forum for experts to exchange practical experience and share optimal solutions to improve treatment outcomes.
With well-structured content, the workshop included multiple in-depth sessions focusing on key factors affecting the success rate of in vitro fertilization (IVF). The presentations were not limited to theory but closely linked to clinical practice, helping participants gain a comprehensive view and apply knowledge effectively in their professional work.
One of the highlights of the workshop was the participation of many reputable domestic and international experts. Scientific reports presented by experienced professionals provided multidimensional perspectives and updated the latest trends in reproductive support.
In addition, open discussion sessions created opportunities for delegates to interact directly, ask questions, and analyze specific clinical cases together. This is the core value of the workshop – a place to connect knowledge and promote the overall development of the field.
Eurofins GENTIS actively participates and strengthens professional connections
At this workshop, Eurofins GENTIS was represented by a team of experts including Dr. Nguyen Quang Vinh, Dr. Pham Dinh Minh, and Mr. Hoang Dinh Khiem. Their presence not only demonstrated a proactive spirit in learning and updating knowledge but also affirmed the organization’s active role in the reproductive medicine community.
Through the event, Eurofins GENTIS experts had the opportunity to meet, exchange ideas, and connect with many colleagues in obstetrics, gynecology, and reproductive support. This serves as an important foundation for expanding professional collaboration, while sharing practical experience to improve the quality of testing and treatment services.
The workshop “Advances in Reproductive Medicine 13” delivered valuable content focusing on trends and advanced technologies in reproductive support. Some key topics included:
- Application of new technologies in embryo culture and selection
- The role of genetics in optimizing IVF outcomes
- Personalized treatment strategies for infertile patients
- Practical experience in improving implantation and successful pregnancy rates
These topics not only updated knowledge but also provided practical solutions that can be directly applied to treatment processes, contributing to improved efficiency for reproductive support centers.
Highlights from Eurofins GENTIS presentation
One of the key highlights of the workshop was the presentation by Dr. Pham Dinh Minh – R&D Director of Eurofins GENTIS, in session 2 with the topic: “Genetics and new technologies in reproductive support”. The presentation titled: “Enhancing IVF efficiency and success through genetic testing” attracted significant attention from participants.
In his presentation, Dr. Pham Dinh Minh shared the latest updates on the role of genetic testing in assisted reproduction. In particular, preimplantation genetic testing (PGT) was emphasized as an effective solution to:
- Detect chromosomal abnormalities early
- Select healthy embryos to improve implantation potential
- Reduce the risk of miscarriage and genetic disorders
- Optimize IVF cycle success rates
The presentation was not only highly academic but also had clear practical application, helping clinicians gain additional evidence to make appropriate treatment decisions for each patient.
Eurofins GENTIS’s presentation received positive feedback from participants. Many experts appreciated the up-to-date, scientific, and practical value of the content. Discussions and questions around genetics reflected the growing interest of the medical community in this field. This also highlights an inevitable trend in modern medicine: personalized treatment based on genetic foundations to achieve optimal outcomes for patients.
Affirming a sustainable development direction
Participation in prestigious scientific workshops such as “Advances in Reproductive Medicine 13” clearly demonstrates Eurofins GENTIS’s development orientation: continuous learning, technological updates, and improvement of professional quality.
In the context of rapidly advancing medicine, continuously updating knowledge and technology is essential to maintain service quality. Eurofins GENTIS understands that only by leading in innovation and scientific application can it deliver the best value to customers and the community.
Through training activities, workshops, and professional collaborations, Eurofins GENTIS not only enhances its internal capabilities but also contributes to knowledge sharing and the overall development of reproductive medicine in Vietnam.
In the future, Eurofins GENTIS will continue to promote research and application of advanced genetic testing solutions, working alongside doctors and reproductive centers to improve treatment outcomes and bring the opportunity of parenthood to more families.
This event was not just a scientific workshop but also a testament to the spirit of collaboration, innovation, and continuous development within the reproductive medicine community. With its positive contributions, Eurofins GENTIS continues to affirm its role as one of the pioneers in genetic testing, accompanying the mission of improving population quality and reproductive health in Vietnam.
[content_more] => [meta_title] => Eurofins GENTIS participates in the workshop “Advances in Reproductive Medicine 13”: updating soluti [meta_description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support successfully organized the scientific workshop “Advances in Reproductive Medicine 13” with the main theme: “How to improve the success rate of IVF cycles”. This is one of [meta_keyword] => GENTIS [thumbnail_alt] => [post_id] => 1418 [category_id] => 14 ) [6] => stdClass Object ( [id] => 1417 [id_crawler] => [category_product] => NULL [thumbnail] => 800x600-web-1.png [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2026-03-19 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-03-19 08:42:43 [updated_time] => 2026-03-24 15:16:17 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-will-present-at-the-workshop-advances-in-reproductive-medicine-13 [title] => Eurofins GENTIS will present at the workshop “Advances in Reproductive Medicine 13” [description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support will organize the scientific workshop “Advances in Reproductive Medicine 13” with the theme: “How to improve IVF cycle success rates.” This is one of the most important annual academic events in the field of reproductive support in Vietnam, attracting significant attention from doctors, scientists, embryologists, and healthcare managers in reproductive medicine. [content] =>In the context of the increasing demand for infertility treatment, along with the rapid development of biotechnology and genetics, updating scientific advances and sharing practical experience in IVF (in vitro fertilization) treatment has become especially essential. The workshop “Advances in Reproductive Medicine 13” is organized to create a prestigious scientific forum where leading experts can discuss new trends, current challenges, and solutions to improve treatment outcomes in reproductive support.
An academic forum gathering leading experts in reproductive support
According to the agenda, the workshop will include 4 in-depth scientific sessions focusing on key topics in current reproductive practice, including:
- Ovarian stimulation
- Genetics and new technologies in reproductive support
- Quality management in reproductive support
- Risk management and quality improvement
The discussion sessions are designed to provide a comprehensive perspective on factors affecting IVF success rates, from clinical strategies and advanced testing technologies to quality management systems and risk control in laboratories and reproductive centers.
In particular, the second session, themed “Genetics and new technologies in reproductive support,” is expected to deliver updated insights into the role of genetic testing techniques, sequencing technologies, and genetic applications in improving infertility treatment outcomes.
PhD Pham Dinh Minh to present on gene testing applications in IVF
At Session 2: “Genetics and new technologies in reproductive support,” PhD Pham Dinh Minh – R&D Director of Eurofins GENTIS will present a report titled: “Enhancing IVF efficiency and success rates through gene testing and genetics.” The presentation will take place from 10:15 to 12:00 on March 28, 2026, at Melia Hanoi Hotel.
In recent years, gene testing techniques and genetic analysis have become an essential part of reproductive medicine. Advances in next-generation sequencing (NGS) and modern genetic analysis methods allow early detection of genetic abnormalities, enabling clinicians to make more precise treatment decisions.
The application of genetic testing in IVF can bring several benefits such as:
- Screening for chromosomal abnormalities in embryos
- Detecting hereditary diseases that may be passed to future generations
- Optimizing embryo selection for transfer
- Improving implantation potential and pregnancy success rates
Through this presentation, PhD Pham Dinh Minh will share the latest updates on genetic testing technologies in reproductive support and analyze how these methods can contribute to improving IVF treatment outcomes in clinical practice.
An experienced expert in genetics and omics sciences
PhD Pham Dinh Minh is a scientist with many years of experience in Biochemistry, Omics sciences, Genetics, and medical testing. With over 10 years of experience in teaching and research, he has participated in numerous domestic and international scientific projects, making significant contributions to the development of biotechnology applications in medicine.
In terms of scientific publications, Dr. Minh is the author and co-author of more than 45 scientific papers, including over 23 articles published in international journals. His research focuses on applications of nanobiotechnology, genome analysis, and innovative technological solutions for disease diagnosis and treatment.
Additionally, Dr. Minh is the lead author of one book chapter and co-author of another chapter in a monograph on nanobiotechnology published by Wiley in 2023—one of the world’s most reputable scientific publishers.
In research activities, he is currently the principal investigator of one national-level project funded by Nafosted and two projects under the Ministry of Science and Technology related to nanobiotechnology and stem cells. He also serves as a key member in two international collaborative projects and two national-level projects.
Beyond research, Dr. Minh is actively involved in scientific training. He has supervised 1 PhD candidate, 5 master’s students, and 6 bachelor’s students, contributing to the development of the next generation of scientists in biotechnology and genetics.
Opportunities for knowledge update and professional networking
The workshop “Advances in Reproductive Medicine 13” is expected to provide valuable scientific insights, helping doctors and specialists stay updated with the latest trends in reproductive medicine.
The participation of leading experts and in-depth presentations will create opportunities for delegates to exchange experiences, discuss clinical challenges, and explore solutions to improve IVF success rates.
For doctors, embryologists, and researchers in reproductive medicine, this is also an important occasion for professional networking, sharing practical experience, and accessing new technologies in infertility diagnosis and treatment.
With its highly practical theme and numerous specialized reports, the workshop promises to contribute to the development of reproductive support in Vietnam and open new approaches to enhance treatment effectiveness for patients.
We look forward to welcoming doctors and experts at the workshop “Advances in Reproductive Medicine 13” and encourage you not to miss the presentation by PhD Pham Dinh Minh on the application of gene testing and genetics in improving IVF outcomes.
[content_more] => [meta_title] => Eurofins GENTIS will present at the workshop “Advances in Reproductive Medicine 13” [meta_description] => On March 28, 2026, at Melia Hanoi Hotel, the Hanoi Society for Reproductive Support will organize the scientific workshop “Advances in Reproductive Medicine 13” with the theme: “How to improve IVF cycle success rates.” This is one of the most important an [meta_keyword] => Gentis,Hasar [thumbnail_alt] => [post_id] => 1417 [category_id] => 14 ) [7] => stdClass Object ( [id] => 1415 [id_crawler] => [category_product] => NULL [thumbnail] => 800x600-web.png [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2026-03-13 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2026-03-13 14:02:45 [updated_time] => 2026-03-13 14:06:08 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => Eurofins-GENTIS-launches-PGT-FAST-Embryo-genetic-screening-solution-with-outstanding-turnaround-time [title] => Eurofins GENTIS launches PGT-FAST – Embryo genetic screening solution with outstanding turnaround time [description] => In recent years, advancements in assisted reproductive technologies have provided the opportunity for millions of couples worldwide to become parents. However, beyond creating embryos through in vitro fertilization (IVF), selecting embryos with good genetic quality remains a crucial factor in achieving successful pregnancies. Numerous studies have shown that chromosomal abnormalities in embryos are among the common causes of implantation failure, early miscarriage, or genetic syndromes in children after birth. Therefore, preimplantation genetic testing (PGT) has become increasingly important in modern IVF procedures. To support fertility centers in optimizing embryo selection, Eurofins GENTIS has launched a new test, PGT-FAST – an embryo genetic screening solution with the outstanding advantage of delivering results in just 15 hours. [content] =>
Comprehensive Chromosome Analysis for Embryo Genetic Screening
PGT-FAST is a preimplantation genetic test performed before embryo transfer during IVF. By analyzing embryonic cells, the test evaluates the chromosomal status of embryos and detects abnormalities that may affect pregnancy development. The test allows for the analysis of all 24 chromosomes in the embryo, identifying numerical chromosomal abnormalities, also known as aneuploidy. These abnormalities can lead to serious genetic syndromes or prevent normal embryo development.
In addition, PGT-FAST can detect large structural chromosomal abnormalities, such as deletions or duplications of 5Mb or larger. These abnormalities may be associated with genetic syndromes that impact the health and development of the child. Embryo genetic screening provides fertility specialists with scientific evidence to select embryos with normal chromosomal complements, thereby increasing implantation rates and improving IVF treatment outcomes.
Significantly Reduced Turnaround Time
One of the most notable features of PGT-FAST is its ability to significantly shorten analysis and reporting time. The optimized process allows results to be delivered within 15 hours from sample analysis. Rapid turnaround time offers practical benefits for both fertility centers and patients. Physicians can access embryo genetic results more quickly, enabling timely and appropriate clinical decisions during treatment. For many couples undergoing IVF, a shorter waiting period also helps reduce psychological stress and provides greater control over their treatment plan.
Application of Next-Generation Sequencing Technology
PGT-FAST is based on Next Generation Sequencing (NGS), one of the most advanced and accurate genetic analysis technologies available today. The sequencing system used in this test is based on the Illumina platform (USA), combined with specialized genetic data analysis software, enabling highly accurate detection of abnormalities. The test achieves high sensitivity and specificity, ensuring reliable results for embryo genetic analysis. Utilizing modern analytical technologies not only improves test accuracy but also optimizes processes and reduces turnaround time.
The introduction of PGT-FAST represents another step forward in expanding Eurofins GENTIS’ genetic testing ecosystem in the field of assisted reproduction. This new testing solution is expected to provide fast, accurate, and efficient options for IVF centers and families seeking the opportunity to welcome healthy babies.
In an era where reproductive medicine increasingly emphasizes genetic factors, the development of advanced testing solutions like PGT-FAST is expected to further enhance treatment quality and help families move closer to their dream of becoming parents.
[content_more] => [meta_title] => Eurofins GENTIS launches PGT-FAST – Embryo genetic screening solution with outstanding turnaround ti [meta_description] => To support fertility centers in optimizing embryo selection, Eurofins GENTIS has launched a new test, PGT-FAST – an embryo genetic screening solution with the outstanding advantage of delivering results in just 15 hours. [meta_keyword] => GENTIS,PGT-FAST [thumbnail_alt] => [post_id] => 1415 [category_id] => 14 ) )
Announcement: Update on non-invasive prenatal paternity DNA testing service
Genetic testing ecosystem in reproductive support at Eurofins GENTIS
Eurofins GENTIS announces appointment of chief executive officer
Working announcement during Hung Kings’ Commemoration Day and April 30 – May 1 holiday
The prenatal class “Proper vaccination – protecting mothers, strengthening babies” concluded with many emotions
Eurofins GENTIS participates in the workshop “Advances in Reproductive Medicine 13”: updating solutions to improve IVF success rates
Eurofins GENTIS will present at the workshop “Advances in Reproductive Medicine 13”
Eurofins GENTIS launches PGT-FAST – Embryo genetic screening solution with outstanding turnaround time
Please fill in the information below to receive our supports and consultations!
Please fill in the information below to receive our supports and consultations!
